Goranov, S., Goranova-Marinova, V. Bortezomib (VELCADE®) - a new therapeutic strategy for patients with refractory multiple myeloma,
, .
Goranov, S., Goranova-Marinova, V. .
Bortezomib (VELCADE®) - a new therapeutic strategy for patients with refractory multiple myeloma.
: , .
Goranov, S., Goranova-Marinova, V. ()
Bortezomib (VELCADE®) - a new therapeutic strategy for patients with refractory multiple myeloma,
:
Goranov, S., & Goranova-Marinova, V.
().
Bortezomib (VELCADE®) - a new therapeutic strategy for patients with refractory multiple myeloma. Folia Medica; Folia Medica.